<?xml version='1.0' encoding='utf-8'?>
<document id="26151793"><sentence text="Serum Sirolimus Level Elevation Induced by Acitretin: Report of a Novel Drug-Drug Interaction."><entity charOffset="43-52" id="DDI-PubMed.26151793.s1.e0" text="Acitretin" /></sentence><sentence text="Long-term immunosuppression in the organ transplant recipient (OTR) population places these individuals at higher risk of developing skin malignancies" /><sentence text=" Oral retinoids have become a useful tool for pharmacologic prophylaxis in the OTR population"><entity charOffset="6-15" id="DDI-PubMed.26151793.s3.e0" text="retinoids" /></sentence><sentence text=" Immunosuppressants that inhibit mTOR, such as sirolimus, may be used in combination with a systemic retinoid for chemoprophylaxis of cutaneous malignancies"><entity charOffset="47-56" id="DDI-PubMed.26151793.s4.e0" text="sirolimus" /><entity charOffset="101-109" id="DDI-PubMed.26151793.s4.e1" text="retinoid" /><pair ddi="false" e1="DDI-PubMed.26151793.s4.e0" e2="DDI-PubMed.26151793.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26151793.s4.e0" e2="DDI-PubMed.26151793.s4.e1" /></sentence><sentence text=" We present the case of a male patient status post second renal transplant who developed an abrupt and unexpected rise in sirolimus levels to supra-therapeutic levels after initiation of prophylactic acitretin for innumerable squamous cell carcinomas (SCC)"><entity charOffset="200-209" id="DDI-PubMed.26151793.s5.e0" text="acitretin" /></sentence><sentence text=" The sirolimus levels returned to baseline after cessation of acitretin"><entity charOffset="5-14" id="DDI-PubMed.26151793.s6.e0" text="sirolimus" /><entity charOffset="62-71" id="DDI-PubMed.26151793.s6.e1" text="acitretin" /><pair ddi="false" e1="DDI-PubMed.26151793.s6.e0" e2="DDI-PubMed.26151793.s6.e0" /><pair ddi="false" e1="DDI-PubMed.26151793.s6.e0" e2="DDI-PubMed.26151793.s6.e1" /></sentence><sentence text=" Systemic drug-drug interactions are an important phenomenon, especially in the solid OTR population" /><sentence text=" It is postulated that this interaction was mediated by acitretin inhibition of CYP3A4, the primary enzyme responsible for sirolimus metabolism" /><sentence text=" The Drug Interaction Probability Scale (DIPS) indicates this was a &quot;probable&quot; drug-drug interaction" /><sentence text=" To date, this interaction has not been reported in the literature" /><sentence text=" This case accentuates the importance of close monitoring of solid OTRs for adverse medication interactions when multiple medications are taken" /><sentence text="" /></document>